Insights

Data Modernization BioNTech's data stack includes AWS Glue, DBT, SAP ERP, PyTorch and Celonis, signaling a mature data driven operating model. A sales focus could be on end to end data modernization, cloud analytics and AI enablement to accelerate research, production planning and commercial decision making.

Manufacturing Transformation The company is consolidating sites and shifting away from pandemic era manufacturing, indicating a need for scalable bioprocess automation, MES integration with SAP, and digital twin based process optimization to support new immunotherapy pipelines.

Trials and Compliance With active immunotherapy programs and industry event engagement, BioNTech could benefit from trial operations optimization, data management and regulatory intelligence services. Potential offerings include clinical data platforms, eTMF and eConsent workflows, patient recruitment analytics and global regulatory monitoring.

Strategic Partnerships As a leader in mRNA based immunotherapies, there is opportunity for co development, licensing or collaboration on novel platforms and manufacturing capabilities, particularly with data and AI driven R&D partnerships. We can support alliance creation, data collaboration frameworks and joint development program management.

Global Growth Enablement A global biotechnology company with operations in Europe and beyond may require international regulatory affairs tooling, localization and privacy compliance, plus cross border data integration. Opportunities include regulatory affairs automation, localization services, HR and workforce analytics integration, and cross border governance solutions.

BioNTech SE Tech Stack

BioNTech SE uses 8 technology products and services including AWS Glue, SCADA, SAP Financial Accounting, and more. Explore BioNTech SE's tech stack below.

  • AWS Glue
    Big Data Processing
  • SCADA
    Control Systems
  • SAP Financial Accounting
    Enterprise Resource Planning
  • Polyfill
    Javascript Libraries
  • TensorFlow
    Machine Learning
  • TypeScript
    Programming Languages
  • Apache Groovy
    Programming Languages
  • Atlassian Confluence
    Wikis

Media & News

BioNTech SE's Email Address Formats

BioNTech SE uses at least 2 format(s):
BioNTech SE Email FormatsExamplePercentage
First.Last@biontech.comJohn.Doe@biontech.com
91%
FLast@biontech.comJDoe@biontech.com
8%
First@biontech.comJohn@biontech.com
1%
First.Last@biontech.deJohn.Doe@biontech.de
90%
FLast@biontech.deJDoe@biontech.de
6%
LF@biontech.deDJ@biontech.de
2%
Last.First@biontech.deDoe.John@biontech.de
2%

Frequently Asked Questions

What is BioNTech SE's phone number?

Minus sign iconPlus sign icon
You can contact BioNTech SE's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is BioNTech SE's stock symbol?

Minus sign iconPlus sign icon
BioNTech SE is a publicly traded company; the company's stock symbol is BNTX.

What is BioNTech SE's official website and social media links?

Minus sign iconPlus sign icon
BioNTech SE's official website is biontech.com and has social profiles on LinkedInCrunchbase.

How much revenue does BioNTech SE generate?

Minus sign iconPlus sign icon
As of July 2026, BioNTech SE's annual revenue is estimated to be $3B.

What is BioNTech SE's SIC code NAICS code?

Minus sign iconPlus sign icon
BioNTech SE's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does BioNTech SE have currently?

Minus sign iconPlus sign icon
As of July 2026, BioNTech SE has approximately 5.2K employees across 6 continents, including EuropeNorth AmericaAsia. Key team members include Chief Executive Officer & Co-Founder: U. S.Ceo: H. B.Chief Executive Officer: F. K.. Explore BioNTech SE's employee directory with LeadIQ.

What industry does BioNTech SE belong to?

Minus sign iconPlus sign icon
BioNTech SE operates in the Biotechnology Research industry.

What technology does BioNTech SE use?

Minus sign iconPlus sign icon
BioNTech SE's tech stack includes AWS GlueSCADASAP Financial AccountingPolyfillTensorFlowTypeScriptApache GroovyAtlassian Confluence.

What is BioNTech SE's email format?

Minus sign iconPlus sign icon
BioNTech SE's email format typically follows the pattern of First.Last@biontech.com. Find more BioNTech SE email formats with LeadIQ.

How much funding has BioNTech SE raised to date?

Minus sign iconPlus sign icon
As of July 2026, BioNTech SE has raised $2B in funding. The last funding round occurred on Oct 13, 2025 for $70M.

When was BioNTech SE founded?

Minus sign iconPlus sign icon
BioNTech SE was founded in 2008.
BioNTech SE logo

BioNTech SE

Biotechnology ResearchRhineland-palatinate, Germany5001-10000 Employees

BioNTech SE is a global biotechnology company that develops immunotherapies designed to harness the immune system to treat cancer and infectious diseases, with a focus on mRNA technologies. It is headquartered in Mainz, Germany, at 12 An der Goldgrube, Mainz, Rhineland-Palatinate 55131. The company was founded in 2008 by scientists and physicians to translate science into survival and has conducted fundamental research in mRNA technologies for individualized cancer medicine for more than a decade. BioNTech operates globally and employs between 5,001 and 10,000 people. Its website is https://biontech.com.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
BNTX
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2008
Employees
5001-10000

Section iconFunding & Financials

  • $2B

    BioNTech SE has raised a total of $2B of funding over 12 rounds. Their latest funding round was raised on Oct 13, 2025 in the amount of $70Mas a grant.

  • $1B$10B

    BioNTech SE's revenue is estimated to be in the range of $1B$10B

Section iconFunding & Financials

  • $2B

    BioNTech SE has raised a total of $2B of funding over 12 rounds. Their latest funding round was raised on Oct 13, 2025 in the amount of $70Mas a grant.

  • $1B$10B

    BioNTech SE's revenue is estimated to be in the range of $1B$10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.